Orantinib
| CAS号 | 252916-29-3 | 货号 | BCP01984 |
| 中文名 | Orantinib | ||
| 英文名 | Orantinib | ||
| 中文别名 | |||
| 英文别名 | TSU68; TSU 68; TSU-68; SU6668; SU 6668; SU-6668; | ||
| 分子式 | C18H18N2O3 | 分子量 | 310.35 |
| 生物活性 | Orantinib, also known as TSU-68；SU6668, is an orally bioavailable receptor tyrosine kinase inhibitor. Orantinib binds to and inhibits the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR), thereby inhibiting angiogenesis and cell proliferation. Orantinib also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. Check for active clinical trials or closed clinical trials using this agent. | ||
| 信号通路 | Angiogenesis/Protein Tyrosine Kinase | ||
| 靶 点 | PDGFR VEGFR FGFR | ||
|
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target12
购于瀚香生物(Biochempartner)的Orantinib(CAS:252916-29-3)被引用 |
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！